申请人:S&T Global Inc.
公开号:EP3831841A1
公开(公告)日:2021-06-09
A compound of the Formula (I) is disclosed:
or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification. Also described are a pharmaceutical composition comprising the same and a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, lung, and liver, and kindey diseases, and hair loss using the same.
公开了一种式 (I) 的化合物:
或其药学上可接受的盐,其中符号如说明书中所定义。还描述了包含该化合物的药物组合物,以及使用该化合物治疗或预防病毒感染、炎症、干眼症、中枢神经失调、心血管疾病、癌症、肥胖症、糖尿病、肌肉萎缩症、肺病、肝病、肾病和脱发的方法。